LUCD insider filings
Lucid Diagnostics Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-05-21. Screen LUCD transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for LUCD between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Lucid Diagnostics Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-21 | 4 | Matheis Dennis — Director | Purchase (P): 245,000 @ $1.00 | EDGAR |
| 2026-02-24 | 4 | Matheis Dennis — Director | Grant/award (A): 123,000 @ $0 | EDGAR |
| 2026-02-24 | 4 | White Debra — Director | Grant/award (A): 123,000 @ $0 | EDGAR |
| 2026-02-24 | 4 | O'Neil Shaun — President and COO | Grant/award (A): 620,000 @ $0 | EDGAR |
| 2026-02-24 | 4 | Gordon Michael Adam — General Counsel and Secretary | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2026-02-24 | 4 | Lapidus Stanley — Director | Grant/award (A): 123,000 @ $0 | EDGAR |
| 2026-02-24 | 4 | Cox James L — Director | Grant/award (A): 123,000 @ $0 | EDGAR |
| 2026-02-24 | 4 | Sparks Ronald M — Director | Grant/award (A): 123,000 @ $0 | EDGAR |
| 2026-02-24 | 4 | Aklog Lishan — Chief Executive Officer, Director | Grant/award (A): 2,170,000 @ $0 | EDGAR |
| 2026-02-24 | 4 | SOKOLOV JACQUE J — Director | Grant/award (A): 123,000 @ $0 | EDGAR |
| 2026-02-24 | 4 | MCGRATH DENNIS M — Chief Financial Officer | Grant/award (A): 470,000 @ $0 | EDGAR |
| 2026-02-24 | 4 | PALUMBO JOHN R — Director | Grant/award (A): 123,000 @ $0 | EDGAR |
| 2025-10-07 | 4 | PALUMBO JOHN R — Director | Grant/award (A): 215,000 (derivative) @ $0 | EDGAR |
| 2025-08-22 | 4 | Matheis Dennis — Director | Purchase (P): 100,000 @ $1.02 | EDGAR |
| 2025-05-23 | 4/A | Matheis Dennis — Director | Purchase (P): 187,098 @ $1.29 · Purchase (P): 129,684 @ $1.32 · Purchase (P): 33,218 @ $1.32 | EDGAR |
| 2025-05-22 | 4 | Matheis Dennis — Director | Purchase (P): 187,098 @ $1.29 · Purchase (P): 129,684 @ $1.32 · Purchase (P): 33,218 @ $1.32 | EDGAR |
| 2025-02-21 | 4 | O'Neil Shaun — President and COO | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-02-21 | 4 | Matheis Dennis — Director | Grant/award (A): 112,800 @ $0 | EDGAR |
| 2025-02-21 | 4 | Gordon Michael Adam — General Counsel and Secretary | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-02-21 | 4 | White Debra — Director | Grant/award (A): 112,800 @ $0 | EDGAR |
| 2025-02-21 | 4 | Lapidus Stanley — Director | Grant/award (A): 112,800 @ $0 | EDGAR |
| 2025-02-21 | 4 | Cox James L — Director | Grant/award (A): 112,800 @ $0 | EDGAR |
| 2025-02-21 | 4 | Sparks Ronald M — Director | Grant/award (A): 112,800 @ $0 | EDGAR |
| 2025-02-21 | 4 | Aklog Lishan — Chief Executive Officer, Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-02-21 | 4 | SOKOLOV JACQUE J — Director | Grant/award (A): 112,800 @ $0 | EDGAR |
| 2025-02-21 | 4 | MCGRATH DENNIS M — Chief Financial Officer | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2024-05-09 | 4 | Matheis Dennis — Director | Grant/award (A): 241,500 (derivative) @ $0 | EDGAR |
| 2024-05-08 | 4 | Gordon Michael Adam — General Counsel and Secretary | Grant/award (A): 400,000 @ $0 | EDGAR |
| 2024-05-08 | 4 | O'Neil Shaun — President and COO | Grant/award (A): 400,000 @ $0 | EDGAR |
| 2024-05-08 | 4 | Aklog Lishan — Chief Executive Officer, Director | Grant/award (A): 400,000 @ $0 | EDGAR |
| 2024-05-08 | 4 | MCGRATH DENNIS M — Chief Financial Officer | Grant/award (A): 400,000 @ $0 | EDGAR |
| 2024-02-23 | 4 | White Debra — Director | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2024-02-23 | 4 | Lapidus Stanley — Director | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2024-02-23 | 4 | Cox James L — Director | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2024-02-23 | 4 | Sparks Ronald M — Director | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2024-02-23 | 4 | SOKOLOV JACQUE J — Director | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2024-02-20 | 4 | PAVmed Inc. — 10% owner | Other (J): 3,331,747 | EDGAR |
| 2024-01-30 | 4 | PAVmed Inc. — 10% owner | Other (J): 3,331,771 @ $1.40 | EDGAR |
| 2023-09-27 | 4 | Lapidus Stanley — Director | Sale (S): 200 @ $1.43 · Sale (S): 10,000 @ $1.47 · Sale (S): 10,000 @ $1.43 · Sale (S): 9,747 @ $1.45 | EDGAR |
| 2023-09-27 | 4/A | Lapidus Stanley — Director | Sale (S): 3,405 @ $1.45 · Sale (S): 412 @ $1.44 · Sale (S): 100 @ $1.44 | EDGAR |
| 2023-09-22 | 4 | Lapidus Stanley — Director | Sale (S): 3,405 @ $1.45 · Sale (S): 412 @ $1.44 · Sale (S): 100 @ $1.44 | EDGAR |
| 2023-04-13 | 4/A | PAVmed Inc. — 10% owner | Other (J): 1,145,086 @ $1.84 · Other (J): 197,656 @ $2.78 · Other (J): 221,952 @ $2.48 · Other (J): 331,210 @ $1.66 · Other (J): 1,479,326 @ $1.84 | EDGAR |
| 2023-02-02 | 4 | White Debra — Director | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2023-02-02 | 4 | Lapidus Stanley — Director | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2023-02-02 | 4 | Cox James L — Director | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2023-02-02 | 4 | Sparks Ronald M — Director | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2023-02-02 | 4 | SOKOLOV JACQUE J — Director | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2022-12-02 | 4 | PAVmed Inc. — 10% owner | Other (J): 1,145,086 @ $1.84 · Other (J): 197,656 @ $2.78 · Other (J): 221,952 @ $2.48 · Other (J): 331,210 @ $1.66 · Other (J): 1,479,326 @ $1.84 | EDGAR |
| 2022-09-22 | 4 | Lapidus Stanley — Director | Sale (S): 17,000 @ $1.71 · Sale (S): 16,864 @ $1.70 | EDGAR |
| 2022-08-02 | 4 | White Debra — Director | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Lucid Diagnostics Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-12 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-22 | 8-K | 3.02 — Unregistered Sales of Equity Securities 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-16 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-22 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-24 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-14 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-24 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-23 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-26 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=LUCD returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs